Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 8/21/14 → 7/6/24 |
Funding
- Premier Research International LLC: $334,777.00
NOVOCART 3D-A Phase 3 Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D, Compared to Microfracture in the Treatment of Articular Cartilage Defects
- Ireland, Mary (PI)
- Lattermann, Christian (Former PI)